Dr. Hong on the Significance of Larotrectinib in NTRK-Positive NSCLC - OncLive

David S. Hong, MD, discusses the significance of larotrectinib in the treatment of non–small cell lung cancer and other solid tumors harboring NTRK gene fusions.

David S. Hong, MD, deputy chair, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the significance of larot… [+886 chars]

full article...